FI20011446A0 - Farmaseuttinen, brivudiinia sisältävä, kerran päivässä käytettävä koostumus - Google Patents
Farmaseuttinen, brivudiinia sisältävä, kerran päivässä käytettävä koostumusInfo
- Publication number
- FI20011446A0 FI20011446A0 FI20011446A FI20011446A FI20011446A0 FI 20011446 A0 FI20011446 A0 FI 20011446A0 FI 20011446 A FI20011446 A FI 20011446A FI 20011446 A FI20011446 A FI 20011446A FI 20011446 A0 FI20011446 A0 FI 20011446A0
- Authority
- FI
- Finland
- Prior art keywords
- pharmaceutical composition
- composition containing
- once daily
- daily administration
- containing brivudine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT2001MI000009A ITMI20010009A1 (it) | 2001-01-03 | 2001-01-03 | Composizioni farmaceutica contenente brivudina per la singola somministrazione giornaliera |
Publications (2)
Publication Number | Publication Date |
---|---|
FI20011446A0 true FI20011446A0 (fi) | 2001-07-03 |
FI20011446A FI20011446A (fi) | 2002-07-04 |
Family
ID=11446384
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI20011446A FI20011446A (fi) | 2001-01-03 | 2001-07-03 | Farmaseuttinen, brivudiinia sisältävä, kerran päivässä käytettävä koostumus |
Country Status (20)
Country | Link |
---|---|
AT (1) | AT6141U1 (fi) |
BE (1) | BE1014522A5 (fi) |
CH (1) | CH695662A5 (fi) |
CZ (1) | CZ20012464A3 (fi) |
DK (1) | DK177084B1 (fi) |
ES (1) | ES2192456B1 (fi) |
FI (1) | FI20011446A (fi) |
FR (1) | FR2818907B1 (fi) |
GB (1) | GB2370771A (fi) |
GR (1) | GR1004012B (fi) |
HR (1) | HRPK20010345B3 (fi) |
HU (1) | HUP0102816A3 (fi) |
IE (1) | IE20010413A1 (fi) |
IT (1) | ITMI20010009A1 (fi) |
NL (1) | NL1018431C2 (fi) |
PL (1) | PL348480A1 (fi) |
PT (1) | PT102642B (fi) |
SE (1) | SE0102309L (fi) |
SK (1) | SK287043B6 (fi) |
UA (1) | UA76402C2 (fi) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2239527B1 (es) * | 2004-03-01 | 2006-11-16 | M. Cruz Fernandez Gonzalez | Composicion farmacologica de uso topico para el tratamiento del herpes zoster. |
CN113712928A (zh) * | 2021-09-29 | 2021-11-30 | 重庆市力扬医药开发有限公司 | 经口腔粘膜吸收的溴夫定药物 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0104857A1 (en) * | 1982-09-28 | 1984-04-04 | Beecham Group Plc | Deoxyuridine compounds, methods for preparing them and their use in medicine |
IT1170232B (it) * | 1983-10-31 | 1987-06-03 | Anna Gioia Stendardi | Composizioni terapeutiche ad attivita' antivirale |
US5446031A (en) * | 1991-04-24 | 1995-08-29 | Yamasa Shuyu Kabushiki Kaisha | 1-β-D-arabinofuranosyl-(E)-5-(2-halogenovinyl)uracil derivatives |
PT874631E (pt) * | 1996-01-19 | 2004-04-30 | Glaxo Group Ltd | Utilizacao de valaciclovir para a manufactura de um medicamento para o tratamento de herpes genital por aplicacao diaria unica |
-
2001
- 2001-01-03 IT IT2001MI000009A patent/ITMI20010009A1/it unknown
- 2001-04-25 IE IE20010413A patent/IE20010413A1/en not_active IP Right Cessation
- 2001-05-01 GB GB0110682A patent/GB2370771A/en not_active Withdrawn
- 2001-05-11 HR HR20010345A patent/HRPK20010345B3/xx not_active IP Right Cessation
- 2001-05-29 CH CH00987/01A patent/CH695662A5/de not_active IP Right Cessation
- 2001-06-28 SE SE0102309A patent/SE0102309L/ not_active Application Discontinuation
- 2001-06-29 FR FR0108596A patent/FR2818907B1/fr not_active Expired - Lifetime
- 2001-06-29 DK DKPA200101019A patent/DK177084B1/da not_active IP Right Cessation
- 2001-07-02 NL NL1018431A patent/NL1018431C2/nl not_active IP Right Cessation
- 2001-07-03 FI FI20011446A patent/FI20011446A/fi not_active Application Discontinuation
- 2001-07-04 BE BE2001/0452A patent/BE1014522A5/fr not_active IP Right Cessation
- 2001-07-04 UA UA2001074658A patent/UA76402C2/uk unknown
- 2001-07-04 CZ CZ20012464A patent/CZ20012464A3/cs unknown
- 2001-07-04 SK SK957-2001A patent/SK287043B6/sk not_active IP Right Cessation
- 2001-07-05 PL PL01348480A patent/PL348480A1/xx not_active Application Discontinuation
- 2001-07-05 PT PT102642A patent/PT102642B/pt active IP Right Grant
- 2001-07-05 GR GR20010100322A patent/GR1004012B/el unknown
- 2001-07-05 ES ES200101566A patent/ES2192456B1/es not_active Expired - Fee Related
- 2001-07-05 HU HU0102816A patent/HUP0102816A3/hu unknown
-
2002
- 2002-07-03 AT AT0805702U patent/AT6141U1/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CH695662A5 (de) | 2006-07-31 |
FR2818907B1 (fr) | 2006-05-26 |
GB0110682D0 (en) | 2001-06-20 |
HUP0102816A2 (en) | 2002-10-28 |
NL1018431C2 (nl) | 2002-07-05 |
IE20010413A1 (en) | 2003-04-16 |
GR1004012B (el) | 2002-11-01 |
ITMI20010009A1 (it) | 2002-07-03 |
ES2192456A1 (es) | 2003-10-01 |
ITMI20010009A0 (it) | 2001-01-03 |
SE0102309D0 (sv) | 2001-06-28 |
GR20010100322A (el) | 2002-10-08 |
AT6141U1 (de) | 2003-05-26 |
SE0102309L (sv) | 2002-07-04 |
PT102642A (pt) | 2002-07-31 |
GB2370771A (en) | 2002-07-10 |
HRPK20010345B3 (en) | 2005-02-28 |
UA76402C2 (en) | 2006-08-15 |
DK200101019A (da) | 2002-07-04 |
PT102642B (pt) | 2003-06-30 |
PL348480A1 (en) | 2002-07-15 |
CZ20012464A3 (cs) | 2002-08-14 |
HRP20010345A2 (en) | 2003-08-31 |
SK287043B6 (sk) | 2009-10-07 |
HU0102816D0 (en) | 2001-09-28 |
FR2818907A1 (fr) | 2002-07-05 |
ES2192456B1 (es) | 2005-02-01 |
DK177084B1 (da) | 2011-07-11 |
BE1014522A5 (fr) | 2003-12-02 |
SK9572001A3 (en) | 2003-03-04 |
FI20011446A (fi) | 2002-07-04 |
HUP0102816A3 (en) | 2005-01-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0117618D0 (en) | Pharmaceutical dosage form | |
NO20030627L (no) | Hydrogel-drevet medikament doseringsform | |
NO20022970L (no) | Hydrogel-drevet medikamentdoseringsform | |
HK1059573A1 (en) | Olopatadine formulations for topical administration. | |
FI20011478A (fi) | Farmaseuttinen koostumus | |
EE200300523A (et) | Aripiprasooli ravimlahus peroraalseks manustamiseks | |
ATE355271T1 (de) | Pharmazeutische zusammensetzung | |
AT7729U3 (de) | Pharmazeutische zusammensetzungen enthaltend amlodipinmaleat | |
GB0117619D0 (en) | Pharmaceutical dosage form | |
DK1383482T3 (da) | Fremgangsmåde til fremstilling af en farmaceutisk lavdoseringssammensætning | |
ATA59499A (de) | Pharmazeutische, tolperison enthaltende zubereitung zur oralen verabreichung | |
DE60211183D1 (de) | Pharmazeutische zusammensetzung enthaltend lumiracoxib | |
IL161143A0 (en) | A flash-melt pharmaceutical oral dosage composition | |
NO20034556L (no) | Imidazotriazinon-holdige sammensetninger for nasal administrering | |
FI20022128A (fi) | Farmaseuttinen koostumus | |
ATE348599T1 (de) | Pharmazeutische dronedaron-zusammensetzung für die parenterale verabreichung | |
ATE350016T1 (de) | Bicalutamid enthaltende pharmazeutische zusammensetzung | |
ATE366128T1 (de) | Pharmazeutische zusammensetzung | |
DE10291905D2 (de) | Pharmazeutische Zusammensetzung | |
FI20011446A0 (fi) | Farmaseuttinen, brivudiinia sisältävä, kerran päivässä käytettävä koostumus | |
ATE350029T1 (de) | Pharmazeutische zusammensetzung enthaltend gamma- butyrobetain | |
EE200300378A (et) | Farmatseutiline kompositsioon | |
MXPA01005658A (es) | Composicion farmaceutica de una vez al dia que contiene brivudina. | |
DE50008261D1 (de) | Retardierte darreichungsform enthaltend tramadolsaccharinat | |
SE0004677D0 (sv) | Intraaxonal läkemedelsadministration |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD | Application lapsed |